Entropy Technologies, LP Sage Therapeutics, Inc. Transaction History
Entropy Technologies, LP
- $925 Billion
- Q2 2024
A detailed history of Entropy Technologies, LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Entropy Technologies, LP holds 22,143 shares of SAGE stock, worth $154,779. This represents 0.03% of its overall portfolio holdings.
Number of Shares
22,143
Previous 19,243
15.07%
Holding current value
$154,779
Previous $361 Million
33.32%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding SAGE
# of Institutions
218Shares Held
48.2MCall Options Held
854KPut Options Held
195K-
Vanguard Group Inc Valley Forge, PA6.42MShares$44.9 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$38.3 Million0.99% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$36.5 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$31.2 Million0.81% of portfolio
-
State Street Corp Boston, MA2.47MShares$17.3 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $415M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...